{"schema_version":"secwatch.filing_event.v1","accession":"0001575872-23-000519","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2023-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.158226+00:00","generated_at":"2026-06-17T06:02:54.128535+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TradeUP Acquisition Corp. receives Nasdaq delisting notice for MVLS below $35M","bullets":["Nasdaq notified TradeUP on April 3, 2023 that its Market Value of Listed Securities (MVLS) was below $35M for 30 consecutive business days.","The deficiency is under Nasdaq Listing Rule 5550(b)(2); the notice does not trigger immediate delisting.","Company has 180 days, until October 2, 2023, to regain compliance by achieving MVLS of at least $35M for 10 consecutive business days.","Failure to cure by the deadline will result in a delisting notice; the company may appeal any such determination.","TradeUP is evaluating options to regain compliance, but there is no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001575872-23-000519","json":"https://secwatch.observer/filing/0001575872-23-000519.json","markdown":"https://secwatch.observer/filing/0001575872-23-000519.md","text":"https://secwatch.observer/filing/0001575872-23-000519.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000519/0001575872-23-000519-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000519/uptd-20230303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T06:02:54.128535+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"871a5faf67476231b7fb7ad9e9547709b295ecbf","claim":"Estrella Immunopharma, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"April 3, 2023, TradeUP Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000519/0001575872-23-000519-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}